Corbus Pharmaceuticals Holdings, Inc. CRBP
Analyst Consensus
Price Objectif
Analyst historical
| Analyst | Entreprise | Price during analysis | Target price | Potential gain | Publication date |
|---|---|---|---|---|---|
| Biren Amin | Piper Sandler | 17.82 $ | 35 $ | 17.18 % | 02/12/2024 |
| Jeff Jones | Oppenheimer | 18.41 $ | 60 $ | 41.59 % | 21/10/2024 |
| Kalpit Patel | B.Riley Financial | 19.51 $ | 40 $ | 20.49 % | 20/09/2024 |
| Graig Suvannavejh | Mizuho Securities | 51.58 $ | 74 $ | 22.42 % | 13/09/2024 |
| Jeff Jones | Oppenheimer | 48.3 $ | 88 $ | 39.70 % | 07/08/2024 |
| Andres Maldonado | H.C. Wainwright | 58 $ | 80 $ | 22.00 % | 22/07/2024 |
| Brian Abrahams | RBC Capital | 43.87 $ | 82 $ | 38.13 % | 11/06/2024 |
| Jeff Jones | Oppenheimer | 42.8 $ | 80 $ | 37.20 % | 03/06/2024 |
| Brian Abrahams | RBC Capital | 45 $ | 77 $ | 32.00 % | 20/05/2024 |
| Maury Raycroft | Jefferies | 33.58 $ | 46 $ | 12.42 % | 06/03/2024 |